Cash Flow Statement

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

DexCom Inc., consolidated cash flow statement

US$ in thousands

12 months ended:	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net income (loss)	341,200)	154,700)	493,600)	101,100)	(127,100)
Depreciation and amortization	155,900)	102,000)	67,100)	48,700)	29,100)
Share-based compensation	126,500)	113,400)	119,400)	102,700)	101,900)
Collaborative research and development fee	—)	87,100)	—)	—)	—)
Loss on extinguishment of debt	—)	1,500)	5,900)	—)	—)
Non-cash interest expense	6,300)	88,700)	74,000)	49,600)	17,900)
Non-cash collaborative research and development fee through issuance of common stock	—)	—)	—)	—)	217,700)
Unrealized gain on equity investment	—)	—)	—)	—)	(36,000)
Realized (gain) loss on equity investment	(200)	(11,600)	—)	4,200)	(44,100)
Deferred income taxes, including benefit from valuation allowance release	(21,600)	(4,900)	(277,300)	200)	(2,200)
Other non-cash income and expenses	34,700)	43,600)	13,700)	1,900)	6,900)
Accounts receivable, net	(199,900)	(75,500)	(142,300)	(60,000)	(93,200)
Inventory	49,300)	(112,200)	(114,500)	(49,100)	(25,500)
Prepaid and other assets	(131,600)	(21,300)	(2,400)	(7,200)	(3,000)
Operating lease right-of-use assets and liabilities, net	(5,800)	(100)	(800)	(2,400)	—)
Accounts payable and accrued liabilities	295,100)	58,000)	194,500)	109,000)	56,200)
Accrued payroll and related expenses	8,500)	10,400)	26,100)	16,000)	23,800)
Deferred revenue and other liabilities	11,100)	8,700)	18,600)	(200)	800)
Changes in operating assets and liabilities	26,700)	(132,000)	(20,800)	6,100)	(40,900)
Adjustments to reconcile net income (loss) to cash provided by operating activities	328,300)	287,800)	(18,000)	213,400)	250,300)
Net cash provided by operating activities	669,500)	442,500)	475,600)	314,500)	123,200)
Purchase of marketable securities	(2,266,300)	(2,473,100)	(3,058,200)	(2,030,400)	(452,500)
Proceeds from sale and maturity of marketable securities	2,127,800)	2,666,300)	2,250,500)	1,196,400)	392,100)
Purchases of property and equipment	(364,800)	(389,200)	(199,000)	(180,000)	(67,100)
Acquisitions, net of cash acquired	(3,900)	(30,200)	—)	—)	(11,300)
Other investing activities	(14,300)	10,100)	(11,300)	(1,200)	(1,000)
Net cash used in investing activities	(521,500)	(216,100)	(1,018,000)	(1,015,200)	(139,800)
Net proceeds from issuance of common stock	22,500)	20,300)	15,300)	11,900)	10,800)
Purchases of treasury stock	(557,700)	—)	—)	—)	(100,000)
Proceeds from issuance of convertible notes, net of issuance costs	—)	—)	1,188,800)	—)	836,600)
Repurchase of convertible notes	—)	—)	(282,600)	—)	—)
Proceeds from sale of warrants	—)	—)	—)	—)	183,800)
Purchase of convertible note hedge	—)	—)	—)	—)	(218,900)
Other financing activities	(17,300)	(9,900)	(9,400)	(1,200)	(1,900)
Net cash provided by (used in) financing activities	(552,500)	10,400)	912,100)	10,700)	710,400)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(5,800)	(1,400)	2,100)	(700)	1,800)
Increase (decrease) in cash, cash equivalents and restricted cash	(410,300)	235,400)	371,800)	(690,700)	695,600)
Cash, cash equivalents and restricted cash, beginning of period	1,053,600)	818,200)	446,400)	1,137,100)	441,500)
Cash, cash equivalents and restricted cash, end of period	643,300)	1,053,600)	818,200)	446,400)	1,137,100)

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

Download chart

Cash flow statement item	Description	The company
Net cash provided by operating activities	Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.	DexCom Inc. net cash provided by operating activities decreased from 2020 to 2021 but then increased from 2021 to 2022 exceeding 2020 level.
Net cash used in investing activities	Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.	DexCom Inc. net cash used in investing activities increased from 2020 to 2021 but then slightly decreased from 2021 to 2022.
Net cash provided by (used in) financing activities	Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.	DexCom Inc. net cash provided by (used in) financing activities decreased from 2020 to 2021 and from 2021 to 2022.

DexCom Inc. (NASDAQ:DXCM)

Cash Flow Statement